AU6449200A - Cloning, expression and characterisation of a cdna coding for a rat brain gamma-hydroxybutyrate (ghb) receptor - Google Patents

Cloning, expression and characterisation of a cdna coding for a rat brain gamma-hydroxybutyrate (ghb) receptor

Info

Publication number
AU6449200A
AU6449200A AU64492/00A AU6449200A AU6449200A AU 6449200 A AU6449200 A AU 6449200A AU 64492/00 A AU64492/00 A AU 64492/00A AU 6449200 A AU6449200 A AU 6449200A AU 6449200 A AU6449200 A AU 6449200A
Authority
AU
Australia
Prior art keywords
ghb
hydroxybutyrate
characterisation
cloning
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64492/00A
Inventor
Christian Andriamanpandry
Michel Maitre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Louis Pasteur Strasbourg I
Original Assignee
Universite Louis Pasteur Strasbourg I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Louis Pasteur Strasbourg I filed Critical Universite Louis Pasteur Strasbourg I
Publication of AU6449200A publication Critical patent/AU6449200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU64492/00A 1999-06-18 2000-06-19 Cloning, expression and characterisation of a cdna coding for a rat brain gamma-hydroxybutyrate (ghb) receptor Abandoned AU6449200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9907784A FR2795075A1 (en) 1999-06-18 1999-06-18 New rat brain gamma-hydroxybutyrate receptor and its encoding nucleic acid, useful for identifying agents for treating e.g. epilepsy
FR9907784 1999-06-18
PCT/FR2000/001687 WO2000078948A2 (en) 1999-06-18 2000-06-19 Cloning, expression and characterisation of a cdna coding for a rat brain gamma-hydroxybutyrate (ghb) receptor

Publications (1)

Publication Number Publication Date
AU6449200A true AU6449200A (en) 2001-01-09

Family

ID=9547010

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64492/00A Abandoned AU6449200A (en) 1999-06-18 2000-06-19 Cloning, expression and characterisation of a cdna coding for a rat brain gamma-hydroxybutyrate (ghb) receptor

Country Status (3)

Country Link
AU (1) AU6449200A (en)
FR (1) FR2795075A1 (en)
WO (1) WO2000078948A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406058A1 (en) * 2000-04-10 2001-10-18 Human Genome Sciences, Inc. Tm4sf receptor polynucleotides, polypeptides, and antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003525566A (en) * 1997-11-07 2003-09-02 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド 125 human secreted proteins

Also Published As

Publication number Publication date
FR2795075A1 (en) 2000-12-22
WO2000078948A3 (en) 2001-03-01
WO2000078948A2 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
AU6219398A (en) Use of central cannabinoid receptor antagonists for regulating appetence
AU2711400A (en) Heteroaryl-aryl ureas as igf-1 receptor antagonists
AU4499499A (en) A polypeptide structure for use as a scaffold
AU3764300A (en) Invertebrate biogenic amine receptors
AU4772096A (en) Delta opioid receptor antagonists
PL337809A1 (en) Derivatives of 1-aminoalkyl cyclohexane as antagonists of nmda receptor
EP1224173A4 (en) Pyrazole derivatives as cannabinoid receptor antagonists
AUPP608898A0 (en) New use of prostaglandin E2 antagonists
AU4394799A (en) Retinoid-associated receptor regulators
AU2897497A (en) Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
CZ20011270A3 (en) Tetrahydrobenzazepine derivatives suitable as modulators of dopamine D3 receptors
AU1553199A (en) Antagonists of g-protein-coupled receptor
AU7667300A (en) Use of central cannabinoid receptor antagonist for preparing medicines
AU9164998A (en) Speech coding
AU6586298A (en) Glucagon-like peptide-1 analogs
AU6343998A (en) Constitutively activated serotonin receptors
AU4728799A (en) Bivalent binding molecules of 7 transmembrane g protein-coupled receptors
EP1157038A4 (en) Cloning of a p2y-like 7tm receptor (axor17)
AU6353098A (en) NK-1 receptor antagonists for the treatment of symptoms of irritable bowel syndrome
AU2314195A (en) Benzofuran derivatives as d4 receptor antagonists
AU6425098A (en) Termination of a tension member, for use as a tendon for a tension leg platform
AU1535699A (en) Novel receptors opg-2
AU3339697A (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
AU6449200A (en) Cloning, expression and characterisation of a cdna coding for a rat brain gamma-hydroxybutyrate (ghb) receptor
EP1073681A4 (en) Cloning of a novel 7tm receptor axor-2

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase